Brooklyn, United States
OpenBCI is a pioneering company in the field of neuroscience and biosensing, renowned for its commitment to developing open-source tools for brain-computer interface (BCI). Established in 2014 and headquartered in the United States, the company has been influential in making neurotechnology accessible. Its latest innovation, Galea, exemplifies this ethos by offering an enterprise-level, multi-modal biosensing headset that fuses high-fidelity AR/VR/XR technology with unparalleled biosensing capabilities.
OpenBCI operates in the Hardware and IT industries, emphasizing the transformation of physiological data into actionable insights using both novel hardware and advanced artificial intelligence. The company secured its last investment during a Venture Round on 15 December 2021, attracting notable investors such as BITKRAFT Ventures, NaHCO3, and re.Mind Capital. This backing underlines confidence in OpenBCI's potential to revolutionize neurotechnology and biosensing.
